Anti-Dengue Virus Type IV Antibody, clone 1H10-6

32160702

NA.41

Dengue fever is an acute, mosquito-transmitted viral disease characterized by fever, headache, arthralgia (severe retro-orbital pain), myalgia, rash, nausea, and vomiting. Infections are caused by any of the four closely related, but antigenically distinct virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4). Infection with one of these serotypes does not provide cross-protective immunity, so persons living in a dengue-endemic area can have four dengue infections during their lifetimes. Dengue is primarily an urban disease of the tropics, and the viruses that cause it are maintained in a cycle that involves humans and Aedes aegypti, a domestic, day-biting mosquito that prefers to feed on humans. Although most dengue infections result in relatively mild illness, some can produce Dengue Hemorrhagic Fever (DHF) or dengue shock syndrome, with children being particularly at risk. Although epidemic outbreaks have been reported since 1779, the incidence has been increasing, with global, multiple serotype pandemics intensifying within the last 15 years. There is no specific antiviral therapy for dengue, but for both classical dengue and dengue hemorrhagic fever, symptomatic and supportive measures are effective. Important risk factors for DHF include the strain and serotype of the virus involved, as well as the age, immune status, and genetic predisposition of the patient.

Reacts with the Dengue type 4 virus.

Dengue type 4 virus antigens (H241).

Research Category
Infectious Diseases
Detect Dengue Virus Type IV using this Anti-Dengue Virus Type IV Antibody, clone 1H10-6 validated for use in IF, HI.
Research Sub Category
Infectious Diseases - Viral
Immunofluorescent assay and hemagglutination-inhibition tests.

Final working dilutions must be determined by end user.

Ascites

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

300

mouse

ascites fluid

1H10-6, monoclonal

human

Chemicon^®

immunofluorescence: suitable
inhibition assay: suitable (hemagglutination)

IgG1

dry ice

Maintain at -20°C for up to 12 months from date of receipt and avoid freeze/thaw cycles.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

10 - Combustible liquids

WGK 1